Unidad de Hígado y Trasplante Hepático, Hospital Universitario Austral, Pilar, Argentina; Latin American Liver Research, Educational and Awareness Network (LALREAN).
Sección Hepatología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
J Clin Virol. 2020 May;126:104309. doi: 10.1016/j.jcv.2020.104309. Epub 2020 Mar 6.
Background Argentina is considered a region of low seroprevalence of hepatitis E virus (HEV), however; no studies have evaluated its burden among acute hepatitis cases.
We aimed to estimate the proportion of acute HEV and outcome in a cohort of patients with acute hepatitis from 6 liver units in the Metropolitan area of Buenos Aires (MABA).
We performed a prospective cohort study including patients ≥18 years with acute hepatitis (increase in transaminases x 5 ULN) fromJuly 2016 to May 2018. Severe hepatitis was defined as acute hepatitis + INR> 1.5 and acute liver failure as severe hepatitis + encephalopathy. In patients in whom other etiologies were excluded, HEV tests were performed: anti-HEV IgM/G and HEV-RNA in serum and feces.
Overall, 268 patients with acute hepatitis were included in the study. The most frequent etiologies of acute hepatitis were hepatitis B (67patients, 25 %), hepatotoxicity (65, 24 %) and autoimmune hepatitis (26, 10 %). Acute HEV infection was confirmed in 8 (2.98 %; 95 %CI 1.25-5.63) patients who tested positive for anti-HEV IgM. A total of 63 (23.5 %) patients were hospitalized and 9 (3.3 %) patients died. Overall, 48 (18 %) patients developed severe hepatitis, 6 (2.2 %) have acute liver failure, 6 (1.9 %) underwent liver transplantation and 9 (3.4 %) patients died.
the proportion of acute HEV in MABA was low during the period studied. We believe our findings will aid physicians prioritize other etiologies of acute hepatitis over HEV in order to optimize diagnostic resources and offer better care to their patients.
阿根廷被认为是戊型肝炎病毒(HEV)血清流行率较低的地区,但尚无研究评估其在急性肝炎病例中的负担。
我们旨在评估布宜诺斯艾利斯大都市区(MABA)6 个肝脏单位的急性肝炎患者队列中急性 HEV 的比例及其结局。
我们进行了一项前瞻性队列研究,纳入 2016 年 7 月至 2018 年 5 月期间≥18 岁的急性肝炎(转氨酶升高≥5 倍正常值上限)患者。重型肝炎定义为急性肝炎+INR>1.5,急性肝衰竭定义为重型肝炎+脑病。在排除其他病因的患者中,进行了 HEV 检测:血清和粪便中的抗-HEV IgM/G 和 HEV-RNA。
总体而言,研究纳入了 268 例急性肝炎患者。急性肝炎的最常见病因是乙型肝炎(67 例,25%)、肝毒性(65 例,24%)和自身免疫性肝炎(26 例,10%)。8 例(2.98%;95%CI 1.25-5.63)抗-HEV IgM 阳性患者确诊为急性 HEV 感染。共有 63 例(23.5%)患者住院,9 例(3.3%)患者死亡。总的来说,48 例(18%)患者发生重型肝炎,6 例(2.2%)发生急性肝衰竭,6 例(1.9%)接受肝移植,9 例(3.4%)患者死亡。
研究期间 MABA 急性 HEV 的比例较低。我们认为我们的研究结果将有助于医生优先考虑急性肝炎的其他病因,而不是 HEV,以优化诊断资源并为患者提供更好的治疗。